ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 132313 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 132313; 2) Community: the network communities that were significantly associated with the response to NSC 132313; 3) Molecule: the relationships between components within communities and NSC 132313; 4) MDR: the compounds that were significantly associated with the NSC 132313.

NSC Compound Enrichment Correlation
NSC 102627 Yoshi 864 0.00013525639843218 0.92465799
NSC 638199 Null 0.000135256398432181 0.46540397
NSC 642915 Null 0.000135256398432181 0.74378841
NSC 681644 Camptothecin Derivative 0.000135256398432181 0.84641525
NSC 683557 Camptothecin Derivative 0.000135256398432181 0.77434959
NSC 95099 Bigitalin 0.000135256398432181 0.49312616
NSC 693118 Null 0.000166573147098352 0.69717099
NSC 86368 Null 0.00018406644094143 0.078062592
NSC 135962 Aracytidine 5'-palmitate 0.000184748296800008 0.66962158
NSC 375162 Imidazo[1,2-a]pyridine-6-carboxaldehyde, 2-[4-[[(4,5-dihydro-1H-imidazol-2-yl)hydrazono]methyl]phenyl]-, (4,5-dihydro-1H-imidazol-2-yl)hydrazone, dihydroiodide 0.000184748296800008 0.44878168
Total:90  Current:1    [First] [Prev] [Next] [Last]